Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510060, China
Location status: Recruiting
NCT Number: NCT05472844
This retrospective-prospective bidirectional cohort study aims to observe ocular parameter changes, different surgical/vision recovery strategies and postoperative adverse effects among young children with cataract. The influence on psychology and cognitive function will be taken into consideration as well.
Interested in participating?
Request InfoUp to 18 year
All sexes
Observational
Guangzhou, Guangdong, 510060, China
Location status: Recruiting
Pediatric cataract, one of the leading causes of childhood blindness globally, is complex and of great difficulty in treatment. Pediatric patients with cataract (congenital, traumatic or complicated) are enrolled. In this study, investigators will compare ocular parameter changes, different surgical/vision timing or recovery strategies and adverse effects among young children (age < 18 yo)before and after cataract surgery. The influence on psychology and cognitive function will be taken into consideration as well. The whole blood samples of participants and parents are collected and retained in our biobank for gene sequencing, hoping to explore the genetic factors in association with pathogenesis. For children received cataract surgery, samples of partial anterior capsular tissue and 1 ml aqueous humor were collected during operation for further analysis. Multimodal artificial intelligence analyses are performed to establish accurate diagnosis/treatment scheme and disease prediction model.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline and through study completion, an average of 1 year
Best-corrected visual acuity changes are measured by visual acuity charts (Teller/Lea symbol/ETDRS chart) every 1 year at scheduled time
Time frame: Baseline and through study completion, an average of 1 year
Intraocular pressures are measured by NCT machine
Time frame: Baseline and through study completion, an average of 1 year
Refractive power are measured at baseline and every visit at least every 1 year
Time frame: Baseline and through study completion, an average of 1 year
Ocular biological measurements including axial length, corneal keratometry, anterior chamber angle/depth, corneal endothelial cell number and appearance
Time frame: Baseline and through study completion, an average of 1 year
Incidence of postoperative complications, such as glaucoma-related adverse, myopic shift, strabismus and anisometropia and so on
Time frame: Baseline and through study completion, an average of 1 year
Sleep, depression, cognitive function are measured by questionnaires. Self-Rating Scale of Sleep: minimum value-1 point, maximum value-50, and higher scores mean worse outcome. Hamilton Depression Scale: <7 points-normal, and higher scores mean worse outcome. Loewenstein Cognitive Assessment: for every question, minimum 1 point, and maximum 4 points. Higher scores mean worse outcomes.
Time frame: Baseline and through study completion, an average of 1 year
BMI is measured by technicians in every visit
Time frame: Baseline and through study completion, an average of 1 year
Diastolic and systolic blood pressure are measured by technicians in every visit
Time frame: Baseline and through study completion, an average of 1 year
Stereopsis is measured by Randot Stereotest
Time frame: Baseline and through study completion, an average of 1 year
Retinal thickness is measured and analyzed by OCT
Contact information is provided by the study sponsor or research team.
Zhongshan Ophthalmic Center, Sun Yat-sen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07070037
Amblyopia, Brain Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03063216
Anticipation, Genetic, Congenital Cataract
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07364370
Eye Diseases, Eye Neoplasms
Cairo, Egypt
View Trial DetailsNCT07088796
Amblyopia, Astigmatism
Shanghai, Shanghai Municipality, China
View Trial Details